Market Tracker

04/28 5:16pm ET

Alkermes Plc (NASDAQ:ALKS)

58.25
Delayed Data
As of Apr 28
 +1.95 / +3.46%
Today’s Change
36.71
Today|||52-Week Range
62.50
+4.80%
Year-to-Date

Today’s Trading

Previous close56.30
Today’s open56.55
Day’s range56.11 - 59.09
Volume1,279,560
Average volume (3 months)827,700
Market cap$8.9B
Dividend yield--
Data as of 4:14pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+72.02%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book7.34

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-2.73-1.69%
SGENSeattle Genetics Inc+0.04+0.06%
TSROTESARO Inc+0.98+0.67%
PRGOPerrigo Company PLC-0.07-0.09%
Data as of 4:02pm ET, 04/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts